Home
Posts
With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

And Gallup says that pharma’s favorability rose 8 percentage points to 28%. Is that worth celebrating?

Oct 2, 2025

Subscribe to Cost Curve Apex to read the rest.

Upgrade to Apex to get access to this post and other subscriber-only content.

No posts found